Phase II Trial of Non-Myeloablative Conditioning and Partially HLA-Mismatched (HLA-Haploidentical) Bone Marrow Transplantation (BMT) for Patients With Hematologic Malignancies: Results of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0603

Subjects

Subjects :

Clinical trial
Transplantation
Bone marrow transplantation
Bone transplantation
business.industry
Myeloablative conditioning
Immunology
Medicine
Human leukocyte antigen
Hematology
business

Details

ISSN :

10838791

Volume :

17

Issue :

2

Database :

OpenAIRE

Journal :

Biology of Blood and Marrow Transplantation

Accession number :

edsair.doi.dedup.....bd82ddfdbb7e342a0d6e90ab8e7e3849

Full Text :

https://doi.org/10.1016/j.bbmt.2010.12.007